Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials

Journal of the American College of Cardiology
M Moser, P R Hebert

Abstract

This work was done to determine the role of hypertension treatment in the prevention of disease progression, left ventricular hypertrophy and congestive heart failure. Lowering of blood pressure in hypertensive patients has been reported to reduce morbidity and mortality from strokes and myocardial infarction. Data on primary prevention of disease progression, left ventricular hypertrophy and congestive heart failure have not previously been carefully quantified. All the major long-term hypertension treatment trials over the past 20 years were reviewed. One thousand four hundred ninety-three of 13,342 subjects in the control groups compared with only 95 of 13,389 in the treated groups progressed from less severe to severe hypertension. The incidence of left ventricular hypertrophy in treated compared with control or placebo subjects was 140 of 6,150 and 216 of 6,098 subjects, respectively; congestive heart failure occurred in 240 of 6,923 subjects in the control group compared with only 112 of 6,914 treated subjects. The lowering of blood pressure over a 3- to 5-year period of time is effective in preventing severe disease, left ventricular hypertrophy and congestive heart failure in addition to strokes and myocardial infarctio...Continue Reading

References

Oct 1, 1992·The New England Journal of Medicine·E D FrohlichB Massie
Oct 1, 1985·Journal of Hypertension·M Moser, R W Gifford
Mar 7, 1970·Lancet·A B Carter
Mar 1, 1966·Journal of Chronic Diseases·F W Wolff, R D Lindeman
Nov 1, 1980·The American Journal of Medicine·A Helgeland
Aug 11, 1993·JAMA : the Journal of the American Medical Association·J D NeatonR McDonald

❮ Previous
Next ❯

Citations

Dec 8, 2005·Current Heart Failure Reports·Kevin L Thomas, Eric J Velazquez
Apr 9, 2013·Current Heart Failure Reports·Samuel W Joffe, Robert A Phillips
Nov 7, 2002·Current Hypertension Reports·René L Roberts, Ralph E Small
Jul 16, 2008·Current Hypertension Reports·Domenic A Sica, Henry R Black
Jul 2, 2003·Current Treatment Options in Cardiovascular Medicine·Richard F. Wright
Sep 1, 2007·Current Treatment Options in Cardiovascular Medicine·J Eduardo Rame, Daniel L Dries
Feb 13, 2004·Progress in Cardiovascular Diseases·Natalie Bello, Lori Mosca
May 22, 1997·The American Journal of Cardiology·A Zanchetti
Sep 6, 2003·International Journal of Cardiology·Yutaka TakedaItoh Makoto
Jun 13, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yasuko AotaToshiji Iwasaka
Sep 17, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Koichi HayashiUNKNOWN JATOS Study Group
Jul 11, 2008·Journal of Human Hypertension·S S Franklin, J M Neutel
Sep 14, 2012·Journal of Human Hypertension·P DeviD Xavier
Feb 18, 2005·Journal of Human Hypertension·C de Carvalho FrimmM Cúri
Aug 8, 2002·Clinical and Experimental Pharmacology & Physiology·M Gary Nicholls, A Mark Richards
Jan 5, 2002·The American Journal of Geriatric Cardiology·Warren J Elliott, Henry R Black
Jun 21, 2001·The Journal of Clinical Hypertension·M Moser
Oct 9, 2002·The Journal of Clinical Hypertension·Ray W Gifford
Jan 31, 2003·The Journal of Clinical Hypertension·Marvin Moser
Mar 21, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·UNKNOWN Japanese Society of Hypertension
Sep 23, 2008·Drugs of Today·Sophie Lalande, Bruce D Johnson
Aug 20, 2011·PloS One·Niema M Pahlevan, Morteza Gharib
Dec 1, 2007·Clinical Interventions in Aging·Luis F AmadorJames S Goodwin
Sep 15, 2004·PharmacoEconomics·Luca Degli Esposti, Giorgia Valpiani
Jul 4, 2012·Drugs·Vasiliki V GeorgiopoulouJaved Butler
Aug 31, 2011·World Journal of Cardiology·Sadip PantMurari Barakoti
Sep 8, 2012·ISRN Cardiology·Javed Butler
Oct 20, 2014·Current Cardiology Reports·A Afşin Oktay, Sanjiv J Shah
Sep 22, 2005·The American Journal of the Medical Sciences·Marie Krousel-WoodRichard N Re
Oct 29, 2010·Journal of the American Society of Hypertension : JASH·Alan B MillerGeorge L Bakris
Jan 1, 2009·Journal of the American Society of Hypertension : JASH·Krishna K Gaddam, Suzanne Oparil
Mar 4, 2008·Heart Failure Clinics·Dinko Susic, Edward D Frohlich
Dec 8, 2007·Cardiology Clinics·Raghava S Velagaleti, Ramachandran S Vasan
Oct 2, 2007·Heart Failure Clinics·Dalane W Kitzman, Kurt R Daniel
Nov 28, 2006·Clinics in Geriatric Medicine·Dalane W Kitzman, Kurt R Daniel
Oct 8, 2004·The Journal of Clinical Hypertension·Vasilios Papademetriou
Feb 19, 2005·European Journal of Heart Failure·Ulf Dahlström

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.